<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35147103</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review.</ArticleTitle><Pagination><StartPage>e28771</StartPage><MedlinePgn>e28771</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28771</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000028771</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease. However, the misdiagnosis of ALS always occurs because of atypical clinical manifestations. Since mutations in Cu/Zn superoxide dismutase 1 (SOD1) have been implicated as causative and account for 20% of fALS cases, early genetic sequencing of suspected individuals in ALS pedigrees could be helpful.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">Here we report a Chinese family spanning three generations with fALS. A heterozygous c.125G&gt;A (p.Gly42Asp) missense mutation in exon 2 of SOD1 gene was detected in our proband as well as her 2 siblings and next generation. Phenotypic diversity was also reported among symptomatic individuals.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="METHODS">Peripheral blood samples from the proband were collected and sent for polymerase chain reaction (PCR) and Sanger sequencing of the SOD1 gene at Sanvalley Diagnostics. The other 11 members in the studied family then underwent locus verification.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Butylphthalide, Vitamin B12, Coenzyme Q10 and mouse nerve growth factor is given to the symptomatic members.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">The symptoms of our proband was not improved by treatments at a late stage. She passed away the fourth year of the disease due to respiratory failure. Two siblings of the proband were given active treatments once verified as carrier. Their symptoms are still limited to limb weakness.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">This study suggests genetic sequencing is a powerful tool for the diagnosis of familial ALS. Phenotypic heterogeneity exists among G41D-mutated individuals, which further highlights the importance of genomic strategies for early diagnosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5324-1137</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xinhong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mou</LastName><ForeName>Jingyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongjing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z171100001017019</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant><Grant><GrantID>DFL20152201</GrantID><Agency>Beijing Municipal Administration of Hospitals' Ascent Plan</Agency><Country/></Grant><Grant><GrantID>2013-2-034</GrantID><Agency>Beijing Municipal Health Bureau project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017809" MajorTopicYN="N">Fatal Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>11</Day><Hour>8</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35147103</ArticleId><ArticleId IdType="pmc">PMC8830837</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000028771</ArticleId><ArticleId IdType="pii">00005792-202202110-00020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Es MAV, Hardiman O, Chio A, Al-Chalabi A, Berg LHVDJL. Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, et al. . Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis 2019;10:1199&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844596</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Ando Y. Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener 2015;4:13.doi:10.1186/s40035-015-0036-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4513711</ArticleId><ArticleId IdType="pubmed">26213621</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Couratier P, Blasco H, et al. . Genetics of amyotrophic lateral sclerosis. Rev Neurol (Paris) 2017;173:254&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumer D, Talbot K, Turner MR. Advances in motor neurone disease. J R Soc Med 2014;107:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3883149</ArticleId><ArticleId IdType="pubmed">24399773</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique T, Figlewicz DA, Pericak-Vance MA, et al. . Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2020294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Sapp PE, et al. . Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997;41:210&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Aguirre T, Van den Bosch L, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996;47:1336&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8909456</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HF, Wu ZY. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener 2016;5:03.doi:10.1186/s40035-016-0050-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>1994;Rainero I, Pinessi L, Tsuda T, et al. . SOD1 missense mutation in an Italian family with ALS. 44:347&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pubmed">8309590</ArticleId></ArticleIdList></Reference><Reference><Citation>2006;Stewart HG, Andersen PM, Eisen A, Weber MJCN. Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations. 117:1850&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">16793335</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JA, Min J, Staropoli JF, et al. . SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph Lateral Scler 2012;13:217&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22292843</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Q, Yi Y, Sun X, et al. . The G41D mutation in the superoxide dismutase 1 gene is associated with slow motor neuron progression and mild cognitive impairment in a Chinese family with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2016;87:788&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941133</ArticleId><ArticleId IdType="pubmed">26069299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Zhou Q, Chen Y, et al. . Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review. Sci Rep 2017;7:44606.doi:10.1038/srep44606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5349524</ArticleId><ArticleId IdType="pubmed">28291249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Ma Y, Liu XL, Chen L, Fan DS. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener 2019;8:02.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6325854</ArticleId><ArticleId IdType="pubmed">30637102</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>